LIP
IONS icon

Lighthouse Investment Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Lighthouse Investment Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$373K Sell
4,970
-8,112
-62% -$640K 0.01% 563
2025
Q4 		$1.03M Buy
+13,082
New +$985K 0.03% 473
2024
Q2 		– Sell
-30,379
Closed -$1.32M – 466
2024
Q1 		$1.32M Buy
+30,379
New +$1.45M 0.06% 267

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lighthouse Investment Partners's IONS Position: Q1 2026 in Review

Lighthouse Investment Partners reduced its Ionis Pharmaceuticals (IONS) stake by 62% in Q1 2026, selling an estimated $640K and leaving 4,970 shares worth $373K. The position accounts for 0.01% of the portfolio, ranked #563.

Lighthouse Investment Partners first reported a position in IONS in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.32M in Q1 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Lighthouse Investment Partners held 4,970 shares of Ionis Pharmaceuticals worth $373K as of Q1 2026.
  • Lighthouse Investment Partners sold 8,112 Ionis Pharmaceuticals shares in Q1 2026, an estimated $640K.
  • Ionis Pharmaceuticals made up 0.01% of Lighthouse Investment Partners's portfolio in Q1 2026, its #563 holding.
  • Lighthouse Investment Partners first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • Lighthouse Investment Partners's Ionis Pharmaceuticals position peaked at $1.32M in Q1 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.